Daihan Pharmaceutical Cash Flow Statement

Financials in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Net Income	27,644	33,759	28,426	24,961	22,670
Depreciation & Amortization	9,221	7,282	8,663	9,208	11,411
Loss (Gain) From Sale of Assets	-31.38	-58.03	-22.53	9.4	-41.28
Loss (Gain) From Sale of Investments	-274.01	-303.6	-288.69	-	-
Provision & Write-off of Bad Debts	24.34	17.05	10.8	-33.29	-142.8
Other Operating Activities	2,406	2,115	4,194	2,632	7,386
Change in Accounts Receivable	199.83	-385.22	437.93	-2,172	-10.94
Change in Inventory	-8,134	-3,194	1,271	-4,407	2,969
Change in Accounts Payable	1.13	526.47	-877.61	2,997	-389.71
Change in Other Net Operating Assets	-5,452	-4,115	-2,954	-4,194	-3,234
Operating Cash Flow	25,604	35,643	38,860	28,999	40,617
Operating Cash Flow Growth	-28.16%	-8.28%	34.00%	-28.60%	20.79%
Capital Expenditures	-25,123	-15,801	-21,280	-8,621	-11,850
Sale of Property, Plant & Equipment	31.4	58.04	22.53	-	41.66
Investment in Securities	-12,521	-56,883	3,235	8,635	283.86
Other Investing Activities	0	0	25	180	10
Investing Cash Flow	-37,612	-72,626	-17,998	193.48	-11,515
Short-Term Debt Repaid	-	-	-2,500	-200	-1,000
Long-Term Debt Repaid	-37.12	-38.79	-4,080	-16,817	-4,300
Total Debt Repaid	-37.12	-38.79	-6,580	-17,017	-5,300
Net Debt Issued (Repaid)	-37.12	-38.79	-6,580	-17,017	-5,300
Repurchase of Common Stock	-	-	-	-3,418	-
Dividends Paid	-5,195	-4,329	-3,752	-2,108	-2,108
Financing Cash Flow	-5,232	-4,368	-10,332	-22,543	-7,408
Foreign Exchange Rate Adjustments	-89.82	1,152	113.04	441.94	671.96
Miscellaneous Cash Flow Adjustments	-	-	-	0	-0
Net Cash Flow	-17,329	-40,199	10,644	7,092	22,367
Free Cash Flow	481.53	19,841	17,580	20,378	28,767
Free Cash Flow Growth	-97.57%	12.86%	-13.73%	-29.16%	1.77%
Free Cash Flow Margin	0.23%	9.72%	8.97%	11.06%	16.78%
Free Cash Flow Per Share	-	3374.38	2989.79	3405.01	4794.57
Cash Interest Paid	2.69	1.81	52.47	582.23	451.55
Cash Income Tax Paid	7,913	8,028	8,656	8,869	3,247
Levered Free Cash Flow	-4,364	12,013	13,570	17,249	25,715
Unlevered Free Cash Flow	-4,363	12,014	13,603	17,620	26,009
Change in Working Capital	-13,385	-7,168	-2,123	-7,777	-665.87

Source: S&P Global Market Intelligence. Standard template. Financial Sources.